Johnson & Johnson Revenue 2006-2018 | JNJ

Current and historical revenue for Johnson & Johnson (JNJ) from 2006 to 2018. Revenue can be defined as the sum of all revenue fields included for a company's operating activities. Johnson & Johnson revenue for the twelve months ending June 30, 2018 was $80.684B. Johnson & Johnson revenue for the three months ending June 30, 2018 was $20.830B, representing a 10.57% increase from the same quarter last year.
Johnson & Johnson Annual Revenue
(Millions of US $)
2017 $76,450
2016 $71,890
2015 $70,074
2014 $74,331
2013 $71,312
2012 $67,224
2011 $65,030
2010 $61,587
2009 $61,897
2008 $63,747
2007 $61,095
2006 $53,324
2005 $50,514
Johnson & Johnson Quarterly Revenue
(Millions of US $)
Q2 2018 $20,830
Q1 2018 $20,009
Q4 2017 $20,195
Q3 2017 $19,650
Q2 2017 $18,839
Q1 2017 $17,766
Q4 2016 $18,106
Q3 2016 $17,820
Q2 2016 $18,482
Q1 2016 $17,482
Q4 2015 $17,811
Q3 2015 $17,102
Q2 2015 $17,787
Q1 2015 $17,374
Q4 2014 $18,254
Q3 2014 $18,467
Q2 2014 $19,495
Q1 2014 $18,115
Q4 2013 $18,355
Q3 2013 $17,575
Q2 2013 $17,877
Q1 2013 $17,505
Q4 2012 $17,558
Q3 2012 $17,052
Q2 2012 $16,475
Q1 2012 $16,139
Q4 2011 $16,255
Q3 2011 $16,005
Q2 2011 $16,597
Q1 2011 $16,173
Q4 2010 $15,644
Q3 2010 $14,982
Q2 2010 $15,330
Q1 2010 $15,631
Q4 2009 $16,551
Q3 2009 $15,081
Q2 2009 $15,239
Q1 2009 $15,026
Q4 2008 $15,182
Q3 2008 $15,921
Q2 2008 $16,450
Q1 2008 $16,194
Q4 2007 $15,957
Q3 2007 $14,970
Q2 2007 $15,131
Q1 2007 $15,037
Q4 2006 $13,682
Q3 2006 $13,287
Q2 2006 $13,363
Q1 2006 $12,992
Q4 2005 $12,610
Q3 2005 $12,310
Q2 2005 $12,762
Q1 2005 $12,832
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $350.789B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $243.651B 14.26
Novartis AG (NVS) Switzerland $190.263B 16.32
Merck (MRK) United States $178.137B 15.73
AbbVie (ABBV) United States $145.067B 14.17
Novo Nordisk (NVO) Denmark $114.528B 18.31
Eli Lilly (LLY) United States $109.815B 20.33
Sanofi (SNY) France $104.261B 13.20
AstraZeneca (AZN) United Kingdom $99.745B 10.97
GlaxoSmithKline (GSK) United Kingdom $99.569B 13.30
Bristol-Myers Squibb (BMY) United States $96.944B 17.55